Harbour BioMed created Élancé Therapeutics to develop bispecific antibody drugs for weight loss. Elsewhere, Geron’s CEO is ...
In the second trial, which was open label, 95.6% of participants who switched to DOR/ISL maintained viral suppression ...
Older adults with HIV are at significantly higher risk for cutaneous malignancies when compared with younger patients with HIV.
We’re rationing HIV medications now,” Christopher Mulela, a nurse at our Matero clinic in Zambia, told me quietly. “Patients ...
An Australian man with severe heart failure became the first person in the world to be discharged from hospital with an artificial heart transplant, the researchers and doctors announced on Wednesday ...
In 1985, the first year that a test for HIV became available, Mike Hellman tested positive. It was a terrifying diagnosis at ...
They're pushing for more funding to find effective treatments. Researchers are finally starting to make headway but have a ...
UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...
Bridgette J. Picou, LVN, ACLPN, presented research on the lived experiences of women living with HIV and going through ...
Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results